Toggle light / dark theme

Breaking: sam altman will not return as CEO of openai.


Sam Altman won’t return as CEO of OpenAI, despite efforts by the company’s executives to bring him back, according to co-founder and board director Ilya Sutskever. After a weekend of negotiations with the board of directors that fired him Friday, as well as with its remaining leaders and top investors, Altman will not return to the startup he co-founded in 2015, Sutskever told staff. Emmett Shear, co-founder of Amazon-owned video streaming site Twitch, will take over as interim CEO, Sutskever said.

The decision—which flew in the face of comments OpenAI executives shared with staff on Saturday and early Sunday—could deepen a crisis precipitated by the board’s sudden ouster of Altman and its removal of President Greg Brockman from the board Friday. Brockman, a key engineer behind the company’s successes, resigned later that day, followed by three senior researchers, threatening to set off a broader wave of departures to OpenAI’s rivals, including Google, and to a new venture Altman has been plotting in the wake of his firing.

Distraught employees streamed out of OpenAI headquarters in San Francisco a little after 9 p.m., shortly after the decision was announced internally. One of the people who left the office appeared to be research chief Bob McGrew, who was one of the many executives working to bring Altman and Brockman back.

On the 17th of August 2021, the EU authorized the use of insects as feed for farmed animals such as chickens and pigs. This was a disastrous decision for sentient beings, as it may greatly increase the number of beings who will suffer in animal agriculture. Sadly, this was just one in a series of disastrous decisions that the EU has made regarding insect farming in the last couple of years. Most recently, in February 2022, they authorized the farming of house crickets for human consumption, after having made similar decisions for the farming of mealworms and migratory locusts in 2021.

Many such catastrophic decisions probably lie ahead, seeing that the EU is currently reviewing applications for the farming of nine additional kinds of insects. This brief posts reviews some reflections and potential lessons in light of these harmful legislative decisions.

In an article published yesterday in MIT Technology Review, Rachel Nuwer wrote a thought provoking piece exploring the boundaries between life and death.


Beyond the brain and brain death itself, related efforts are studying and attempting to develop techniques for restoring metabolic function in a number of organs other than the brain after death, including the heart and kidneys, which could greatly enhance organ donation capabilities.

While these developments are promising, researchers caution against overpromising. The path to these medical advancements is paved with years of research and ethical considerations. The exploration into the dying process will surely challenge not only scientific and medical fields but also societal, theological, and legal considerations, as it reshapes our understanding of one of life’s most profound phenomena. At some point, policy and regulations will need to follow—further adding to the complexity of the topic.

The transition from life to death is becoming increasingly blurred as scientific research uncovers previously unknown or poorly understood complexities about the physiology and reversibility of the dying process. This evolving understanding promises to redefine medical practices, extend the window for organ recovery, and challenge our societal notions of life and death. However, this is a true journey, in the sense that the science and its implications will necessarily involve continuous research, ethical and legal considerations, and a need for realistic expectations. While death is a universal experience, what it is and how we go from living to dying are anything but static.

EPFL scientists have crafted a biological system that mimics an electronic bandpass filter, a novel sensor that could revolutionize self-regulated biological mechanisms in synthetic biology.

Synthetic biology holds the promise of enhancing and modifying into innumerable new technologies for the benefit of society. This engineering approach to biology has already reaped benefits in the fields of drug delivery, agriculture, and energy production.

In a paper published in Nature Chemical Biology, EPFL researchers at the Laboratory of Protein Design and Immunoengineering (LPDI) at the School of Engineering have taken an important step in designing more performative biological systems.

In this episode, we explore the Hubble constant problem, which is one of the most intriguing and perplexing mysteries in cosmology. We explain how a recent study used the Hubble Space Telescope to measure the expansion rate of the universe, and how it differs from the prediction of the cosmic microwave background and the standard cosmological model. We also discuss some of the possible implications and solutions for this discrepancy, such as the nature of dark energy, dark matter and dark radiation, and the need to revise our understanding of the universe.

Chapters:
00:00 Introduction.
01:13 Measuring the Hubble Constant.
03:36 Comparing the Results.
05:39 Implications and Solutions.
07:54 Outro.
08:39 Enjoy.

Best Telescopes for beginners:
Celestron 70mm Travel Scope.
https://amzn.to/3jBi3yY

Celestron 114LCM Computerized Newtonian Telescope.
https://amzn.to/3VzNUgU

Celestron – StarSense Explorer LT 80AZ
https://amzn.to/3jBRmds.

Visit our website for up-to-the-minute updates: